# Linaclotide for IBS-C and constipation: a meta-analysis

Source: https://pepvault.app/research/linaclotide-videlock-2013

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Linaclotide](https://pepvault.app/research#linaclotide)

Meta-analysis · people

# Linaclotide beat placebo in IBS-C and chronic constipation trials

Checked against the paper November 2026 Meta-analysis [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

For people using linaclotide (Linzess) for IBS-C or chronic constipation, this pooled analysis of placebo-controlled trials found about 1 in 7 treated people responded who would not have on placebo.

- **Kind:** Meta-analysis
- **Studied in:** People
- **Published:** 2013
- **Journal:** Clin Gastroenterol Hepatol

## What they tested

The team set out to measure how well linaclotide works compared with placebo for adults with irritable bowel syndrome with constipation (IBS-C) or chronic constipation.

## How the study was done

A systematic review and meta-analysis of randomized, placebo-controlled trials in adults with IBS-C or chronic constipation. The search found 7 trials, and 6 were pooled into the analysis.

<!--promo-->

PepVault for iPhone

## Taking linaclotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

In IBS-C, most of the 3 trials used the response measure the U.S. Food and Drug Administration recommends: at least 1 more complete spontaneous bowel movement (CSBM) per week, plus a 30% or more drop in worst daily belly pain scores, for 50% of treatment weeks. By that measure, people on linaclotide 290 μg were 1.95 times as likely to respond as those on placebo (relative risk, 95% CI, 1.3-2.9), and 7 people had to be treated for 1 extra responder (number needed to treat, 95% CI, 5-11). In chronic constipation, 3 trials counted a response as more than 3 CSBMs per week plus a gain of at least 1 per week, for 75% of weeks; here the 290 μg dose gave a relative risk of 4.26 (95% CI, 2.80-6.47), with a number needed to treat of 7 (95% CI, 5-8). Across both conditions, belly pain, bloating and overall symptom severity were lower and stool form was better on linaclotide.

## What it doesn’t show

The pooled result rests on a small number of trials, and the main IBS-C estimate draws on only some of the IBS-C trials. Linaclotide was compared only with placebo, not with other treatments for constipation.

## The paper

Videlock et al. Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis. Clin Gastroenterol Hepatol. 2013.

- [PubMed (PMID 23644388)](https://pubmed.ncbi.nlm.nih.gov/23644388/)
- [The paper (DOI 10.1016/j.cgh.2013.04.032)](https://doi.org/10.1016/j.cgh.2013.04.032)

## The compound

- [Linaclotide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/linaclotide)
- [Linaclotide dose guide](https://pepvault.app/lab/dosage/linaclotide)

## With this study

### Linaclotide

- [Linaclotide: the full reference](https://pepvault.app/peptides/linaclotide)
- [Linaclotide dose guide](https://pepvault.app/lab/dosage/linaclotide)

### Studies

- [Linaclotide plus PEG improved colonoscopy prep quality in 8 RCTs](https://pepvault.app/research/linaclotide-meine-2026)
- [Linaclotide: bowel prep scores similar to double-dose PEG](https://pepvault.app/research/linaclotide-farag-2025)
- [All 8 studies](https://pepvault.app/research#linaclotide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)

## More studies on Linaclotide

- [Linaclotide plus PEG improved colonoscopy prep quality in 8 RCTs](https://pepvault.app/research/linaclotide-meine-2026) Meta-analysis · people · 2026
- [Linaclotide: bowel prep scores similar to double-dose PEG](https://pepvault.app/research/linaclotide-farag-2025) Meta-analysis · people · 2025
- [Linaclotide plus 1 L PEG-Asc: 92% vs 86% adequate prep vs senna](https://pepvault.app/research/linaclotide-apple-2025) Randomized trial · people · 2025
- [Linaclotide raised weekly bowel movements in kids with constipation](https://pepvault.app/research/linaclotide-di-lorenzo-2024) Randomized trial · people · 2024
- [Linaclotide: trend to more bowel movements in kids at higher doses](https://pepvault.app/research/linaclotide-di-lorenzo-2024-38533633) Randomized trial · people · 2024
- [Linaclotide beat placebo for chronic constipation in 12-week trials](https://pepvault.app/research/linaclotide-trials-303-and-01-2011) Randomized trial · people · 2011
- [Every study on Linaclotide](https://pepvault.app/research#linaclotide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking linaclotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking linaclotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Linaclotide

- [Linaclotide: the full reference](https://pepvault.app/peptides/linaclotide)
- [Linaclotide dose guide](https://pepvault.app/lab/dosage/linaclotide)

### Studies

- [Linaclotide plus PEG improved colonoscopy prep quality in 8 RCTs](https://pepvault.app/research/linaclotide-meine-2026)
- [Linaclotide: bowel prep scores similar to double-dose PEG](https://pepvault.app/research/linaclotide-farag-2025)
- [All 8 studies](https://pepvault.app/research#linaclotide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)

<!--promo-->

PepVault for iPhone

## Taking linaclotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Linaclotide](https://pepvault.app/research#linaclotide)

## The library

- [Linaclotide](https://pepvault.app/peptides/linaclotide)
- [Linaclotide dose guide](https://pepvault.app/lab/dosage/linaclotide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
